These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 18465228)

  • 1. Family contact and the management of medication non-adherence in schizophrenia.
    Wilk JE; West JC; Marcus SC; Countis L; Regier DA; Olfson M
    Community Ment Health J; 2008 Oct; 44(5):377-80. PubMed ID: 18465228
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Substance abuse and the management of medication nonadherence in schizophrenia.
    Wilk J; Marcus SC; West J; Countis L; Hall R; Regier DA; Olfson M
    J Nerv Ment Dis; 2006 Jun; 194(6):454-7. PubMed ID: 16772865
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Psychiatrist and patient responses to suspected medication nonadherence in schizophrenia spectrum disorders.
    Hamann J; Lipp ML; Christ-Zapp S; Spellmann I; Kissling W
    Psychiatr Serv; 2014 Jul; 65(7):881-7. PubMed ID: 24686753
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of depot antipsychotic medications for medication nonadherence in schizophrenia.
    West JC; Marcus SC; Wilk J; Countis LM; Regier DA; Olfson M
    Schizophr Bull; 2008 Sep; 34(5):995-1001. PubMed ID: 18093962
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Rationale for the use of long-acting injectable risperidone: a survey of French psychiatrists].
    Misdrahi D; Delgado A; Bouju S; Comet D; Chiariny JF
    Encephale; 2013 May; 39 Suppl 1():S8-14. PubMed ID: 23541914
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Psychiatrists' decision making and monitoring of antipsychotic prescription for elderly schizophrenia patients].
    Jalenques I; Ortega V; Legrand G; Auclair C
    Encephale; 2016 Apr; 42(2):124-9. PubMed ID: 26796558
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Psychiatrists' awareness of partial- and non-adherence to antipsychotic medication in schizophrenia: results from the Australian ADHES survey.
    Kulkarni J; Reeve-Parker K
    Australas Psychiatry; 2015 Jun; 23(3):258-64. PubMed ID: 25783668
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adding or switching antipsychotic medications in treatment-refractory schizophrenia.
    Kreyenbuhl J; Marcus SC; West JC; Wilk J; Olfson M
    Psychiatr Serv; 2007 Jul; 58(7):983-90. PubMed ID: 17602016
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Survey of medication adherence in patients with schizophrenia--Korean ADHES data.
    Kim SW; Yoon JS; Choi SK
    Hum Psychopharmacol; 2006 Dec; 21(8):533-7. PubMed ID: 17133616
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Awareness of illness and nonadherence to antipsychotic medications among persons with schizophrenia.
    Olfson M; Marcus SC; Wilk J; West JC
    Psychiatr Serv; 2006 Feb; 57(2):205-11. PubMed ID: 16452697
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Treatment adherence in schizophrenia. A comparison between patient's, relative's and psychiatrist's opinions].
    Giner J; Cañas F; Olivares JM; Rodriguez A; Burón JA; Rodríguez-Morales A; Roca M
    Actas Esp Psiquiatr; 2006; 34(6):386-92. PubMed ID: 17117335
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Psychiatrists' attitudes to maintenance medication for patients with schizophrenia.
    Patel MX; Nikolaou V; David AS
    Psychol Med; 2003 Jan; 33(1):83-9. PubMed ID: 12537039
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-adherence to antipsychotic medication, relapse and rehospitalisation in recent-onset schizophrenia.
    Morken G; Widen JH; Grawe RW
    BMC Psychiatry; 2008 Apr; 8():32. PubMed ID: 18447935
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Schizophrenia: attitudes of patients and professional carers towards the illness and antipsychotic medication.
    Rettenbacher MA; Burns T; Kemmler G; Fleischhacker WW
    Pharmacopsychiatry; 2004 May; 37(3):103-9. PubMed ID: 15138893
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Psychiatric opinion and antipsychotic selection in the management of schizophrenia.
    Arbuckle MR; Gameroff MJ; Marcus SC; West JC; Wilk J; Olfson M
    Psychiatr Serv; 2008 May; 59(5):561-5. PubMed ID: 18451017
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Psychiatrists' self-reported adherence to evidence-based prescribing practices in the treatment of schizophrenia.
    Young GJ; Mohr DC; Meterko M; Seibert MN; McGlynn G
    Psychiatr Serv; 2006 Jan; 57(1):130-2. PubMed ID: 16399975
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antipsychotic medication use patterns and associated costs of care for individuals with schizophrenia.
    Loosbrock DL; Zhao Z; Johnstone BM; Morris LS
    J Ment Health Policy Econ; 2003 Jun; 6(2):67-75. PubMed ID: 14578539
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Psychiatrists' perceptions of medication adherence among patients with schizophrenia: An international survey.
    Kurokawa S; Kishimoto T; Su KP; Chang JP; Chang HC; Yu X; Rodrigues-Silva N; Nielsen J; Unadkat A; Castle D; Haddad PM; Rocha D; Gadelha A; Kaliora S; Petrides G; Agid O; Tazawa Y; Takamiya A; Horigome T; Kane JM
    Schizophr Res; 2019 Sep; 211():105-107. PubMed ID: 31371039
    [No Abstract]   [Full Text] [Related]  

  • 19. Antipsychotic treatment dosing profile in patients with schizophrenia evaluated with electronic monitoring (MEMS®).
    Acosta FJ; Ramallo-Fariña Y; Bosch E; Mayans T; Rodríguez CJ; Caravaca A
    Schizophr Res; 2013 May; 146(1-3):196-200. PubMed ID: 23474024
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Cost-effectiveness analysis of schizophrenic patient care settings: impact of an atypical antipsychotic under long-acting injection formulation].
    Llorca PM; Miadi-Fargier H; Lançon C; Jasso Mosqueda G; Casadebaig F; Philippe A; Guillon P; Mehnert A; Omnès LF; Chicoye A; Durand-Zaleski I
    Encephale; 2005; 31(2):235-46. PubMed ID: 15959450
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.